BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1737385)

  • 1. Antitumoral and endocrine effects of (+)-vorozole in rats bearing dimethylbenzanthracene-induced mammary tumors.
    De Coster R; Van Ginckel RF; Callens MJ; Goeminne NK; Janssens BL
    Cancer Res; 1992 Mar; 52(5):1240-4. PubMed ID: 1737385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effect of pyridoglutethimide, an aromatase inhibitor, on 7,12-dimethylbenz(a)anthracene-induced mammary tumors of rat.
    Yamamoto T; Urabe M; Tamura T; Kitawaki J; Honjo H; Okada H
    Anticancer Res; 1991; 11(6):1999-2002. PubMed ID: 1776832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel aromatase inhibitor, vorozole, shows antitumor activity and a decrease of tissue insulin-like growth factor-I level in 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Sugamata N; Koibuchi Y; Iino Y; Morishita Y
    Int J Oncol; 1999 Feb; 14(2):259-63. PubMed ID: 9917500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effects of SEF19, a new nonsteroidal aromatase inhibitor, on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in rats.
    Iino Y; Karakida T; Sugamata N; Andoh T; Takei H; Takahashi M; Yaguchi S; Matsuno T; Takehara M; Sakato M; Kawashima S; Morishita Y
    Anticancer Res; 1998; 18(1A):171-6. PubMed ID: 9568073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of combined and sequential treatment with tamoxifen and the aromatase inhibitor vorozole on 7,12-dimethylbenz(a) anthracene-induced mammary carcinoma in the rat.
    Van Ginckel R; Janssens B; Callens M; Goeminne N; Wouters L; De Coster R
    Cancer Chemother Pharmacol; 1996; 38(1):21-8. PubMed ID: 8603447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
    Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
    Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.
    Kelly PA; Asselin J; Caron MG; Raynaud JP; Labrie F
    Cancer Res; 1977 Jan; 37(1):76-81. PubMed ID: 187338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite effects of dehydroepiandrosterone on the growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
    Boccuzzi G; Aragno M; Brignardello E; Tamagno E; Conti G; Di Monaco M; Racca S; Danni O; Di Carlo F
    Anticancer Res; 1992; 12(5):1479-83. PubMed ID: 1444210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CGS 16949A, a new nonsteroidal aromatase inhibitor: effects on hormone-dependent and -independent tumors in vivo.
    Schieweck K; Bhatnagar AS; Matter A
    Cancer Res; 1988 Feb; 48(4):834-8. PubMed ID: 2962734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of aromatase inhibitors, aminoglutethimide, and 4-hydroxyandrostenedione on cyclic rats and rats with 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
    Wing LY; Garrett WM; Brodie AM
    Cancer Res; 1985 Jun; 45(6):2425-8. PubMed ID: 3921242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative effect of the new aromatase inhibitor fadrozole on pre- and postmenopausal models of rat mammary tumor.
    Tanaka M; Yano S; Hasegawa Y; Nakao K
    Arzneimittelforschung; 1994 Jun; 44(6):774-8. PubMed ID: 8053980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
    Klinge CM; Bambara RA; Zain S; Hilf R
    Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer model.
    Lubet RA; Steele VE; DeCoster R; Bowden C; You M; Juliana MM; Eto I; Kelloff GJ; Grubbs CJ
    Carcinogenesis; 1998 Aug; 19(8):1345-51. PubMed ID: 9744527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats.
    Sylvester PW; Ip C; Ip MM
    Cancer Res; 1986 Feb; 46(2):763-9. PubMed ID: 3079669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione on 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats.
    Brueggemeier RW; Li PK
    Cancer Res; 1988 Dec; 48(23):6808-10. PubMed ID: 3141048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effects of a nonsteroidal aromatase inhibitor (CGS 16949A) on 7, 12-dimethylbenz[alpha]anthracene-induced mammary tumors in rats.
    Iino Y; Sugamata N; Owada S; Tago T; Sato H; Yokoe T; Maemura M; Morishita Y; Horiuchi R
    Jpn J Clin Oncol; 1991 Jun; 21(3):153-9. PubMed ID: 1834875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats.
    Sylvester PW; Aylsworth CF; Van Vugt DA; Meites J
    Cancer Res; 1983 Nov; 43(11):5342-6. PubMed ID: 6413057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct inhibiting effects of [D-Trp6]gonadotropin-releasing hormone on the estrogen-sensitive progression of polyoma virus-induced mammary tumors in athymic mice.
    NĂ©ri C; Blangy D; Schatz B; Drieu K; Berebbi M; Martin PM
    Cancer Res; 1990 Sep; 50(18):5892-7. PubMed ID: 2168284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
    Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
    Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
    Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH
    Cancer Res; 1982 Aug; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.